Arcus Biosciences (RCUS) EBITDA Margin Growth (1y) (2018 - 2026)
Arcus Biosciences (RCUS) EBITDA Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1,276.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Arcus Biosciences | 3.57 Bn | 2.75 Bn | - | -35,252.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35,252.00 |
| Dec 31, 2025 | 5,070.00 |
| Sep 30, 2025 | -32,740.00 |
| Jun 30, 2025 | 26,679.00 |
| Mar 31, 2025 | -42,468.00 |
| Dec 31, 2024 | 25,385.00 |
| Sep 30, 2024 | 3,125.00 |
| Jun 30, 2024 | 1,441.00 |
| Mar 31, 2024 | 33,297.00 |
| Dec 31, 2023 | -43,235.00 |
| Sep 30, 2023 | -3,788.00 |
| Jun 30, 2023 | -3,065.00 |
| Mar 31, 2023 | 2,822.00 |
| Dec 31, 2022 | -29,689.00 |
| Sep 30, 2022 | 61,375.00 |
| Jun 30, 2022 | 54,918.00 |
| Mar 31, 2022 | 39,669.00 |
| Dec 31, 2021 | 62,501.00 |
| Sep 30, 2021 | -82,828.00 |
| Jun 30, 2021 | 178,812.00 |